Expression patterns of Th1/Th2 transcription factors in patients with guttate psoriasis

Acta Microbiologica et Immunologica Hungarica

Volumn 60, Issue 2, 2013, Pages 163-174

  Vanaki, Elaheh ^a   Ataei, Mitra ^a   Sanati, Mohammad ^a   Mansouri, Parvine ^b   Mahmoudi, Mahmoud ^c   Zarei, Feresteh ^c   Jadali, Zohreh ^c  

^a NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

autoimmunity; psoriasis; T cell

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; MESSENGER RNA; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GUTTATE PSORIASIS; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; LEUKOCYTE; MALE; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 TH2 BALANCE;

EID: 84880216932     PISSN: 12178950     EISSN: 15882640     Source Type: Journal    
DOI: 10.1556/AMicr.60.2013.2.7     Document Type: Article

References (23)

1. Monteleone, G., Pallone, F., MacDonald, T.T., Chimenti, S., Costanzo, A.: Psoriasis: From pathogenesis to novel therapeutic approaches. Clin Sci (Lond) 120, 1-11 (2011).
2. Ayala, F.: Clinical presentation of psoriasis. Reumatismo 59Suppl 1, 40-45 (2007).
3. Naldi, L., Gambini, D.: The clinical spectrum of psoriasis. Clin Dermatol 25, 510-518 (2007).
4. Austin, L.M., Ozawa, M., Kikuchi, T., Walters, I.B., Krueger, J.G.: The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: A type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 113, 752-759 (1999).
5. Jain, S., Kaur, I.R., Das, S., Bhattacharya, S.N., Singh, A.: T helper 1 to T helper 2 shift in cytokine expression: An autoregulatory process in superantigen-associated psoriasis progression? J Med Microbiol 58(Pt 2), 180-184 (2009).
6. Gordon, K.B., McCormick, T.S.: Evolution of biologic therapies for the treatment of psoriasis. Skinmed 2, 286-294 (2003).
7. Zhu, K., Ye, J., Wu, M., Cheng, H.: Expression of Th1 and Th2 cytokine-associated transcription factors, T-bet and GATA-3, in peripheral blood mononuclear cells and skin lesions of patients with psoriasis vulgaris. Arch Dermatol Res 302, 517-523 (2010).
8. Jadali, Z., Izad, M., Eslami, M.B., Mansouri, P., Safari, R., Bayatian, P.: Th1/Th2 cytokines in psoriasis. Iranian J Pub Health 36, 87-91 (2007).
9. Vollmer, S., Menssen, A., Trommler, P., Schendel, D., Prinz, J.C.: T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells of T helper type 1 and T helper type 2 cells. Eur J Immunol 24, 2377-2382 (1994).
10. Bonifati, C., Ameglio, F.: Cytokines in psoriasis. Int J Dermatol 38, 241-251 (1999).
11. Naito, T., Tanaka, H., Naoe, Y., Taniuchi, I.: Transcriptional control of T-cell development. Int Immunol 23, 661-668 (2011).
12. Grogan, J.L., Locksley, R.M.: T helper cell differentiation: On again, off again. Curr Opin Immunol 14, 366-372 (2002).
13. Romagnani, S.: Regulation of the T cell response. Clin Exp Allergy 36, 1357-1366 (2006).
14. Lima Ede, A., Lima Mde, A.: Reviewing concepts in the immunopathogenesis of psoriasis. An Bras Dermatol 86, 1151-1158 (2011).
15. Ouyang, W., Ranganath, S.H., Weindel, K., Bhattacharya, D., Murphy, T.L., Sha, W.C., Murphy, K.M.: Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 9, 745-755 (1998).
16. Oestreich, K.J., Weinmann, A.S.: T-bet employs diverse regulatory mechanisms to repress transcription. Trends Immunol 33, 78-83 (2012).
17. Frisullo, G., Nociti, V., Iorio, R., Patanella, A.K., Plantone, D., Bianco, A., Marti, A., Cammarota, G., Tonali, P.A., Batocchi, A.P.: T-bet and pSTAT-1 expression in PBMC from coeliac disease patients: New markers of disease activity. Clin Exp Immunol 158, 106-114 (2009).
18. Ilhan, F., Demir, T., Türkçüo?lu, P., Turgut, B., Demir, N., Gödekmerdan, A.: Th1 polarization of the immune response in uveitis in Behçet's disease. Can J Ophthalmol 43, 105-108 (2008).
19. Oliphant, C.J., Barlow, J.L., McKenzie, A.N.: Insights into the initiation of type 2 immune responses. Immunology 134, 378-385 (2011).
20. Macias, E.S., Pereira, F.A., Rietkerk, W., Safai, B.: Superantigens in dermatology. J Am Acad Dermatol 64, 455-472 (2011).
21. Nielsen, M.B., Odum, N., Gerwien, J., Svejgaard, A., Bendtzen, K., Bregentholt, S., Röpke, C., Geisler, C., Dohlsten, M., Kaltoft, K.: Staphylococcal enterotoxin-A directly stimulates signal transduction and interferon-gamma production in psoriatic T-cell lines. Tissue Antigens 52, 530-538 (1998).
22. Michalak-Stoma, A., Pietrzak, A., Szepietowski, J.C., Zalewska-Janowska, A., Paszkowski, T., Chodorowska, G.: Cytokine network in psoriasis revisited. Eur Cytokine Netw 22, 160-168 (2011).
23. Nakajima, H., Nakajima, K., Tarutani, M., Morishige, R., Sano, S.: Kinetics of circulating Th17 cytokines and adipokines in psoriasis patients. Arch Dermatol Res 303, 451-455 (2011).